HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.

about

Hexim1, an RNA-controlled protein hub.

P2860

Q48219788-F16CEBC1-D231-4AFB-8591-12E3EB97C07D

P2860

HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.

Item

http://www.wikidata.org/entity/Q38715966

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

HMBA is a putative HSP70 activ ...... is down-regulated by estrogen.

@en

type

Item

label

HMBA is a putative HSP70 activ ...... is down-regulated by estrogen.

@en

prefLabel

HMBA is a putative HSP70 activ ...... is down-regulated by estrogen.

@en

P1476

HMBA is a putative HSP70 activ ...... is down-regulated by estrogen.

@en

P2093

Bin Su

http://www.w3.org/2001/XMLSchema#string

Chunfang Gan

http://www.w3.org/2001/XMLSchema#string

David Danielpour

http://www.w3.org/2001/XMLSchema#string

Monica Montano

http://www.w3.org/2001/XMLSchema#string

Rati Lama

http://www.w3.org/2001/XMLSchema#string

Viharika Bobba

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA

HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b

Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor

Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells

Tubulin-interactive natural products as anticancer agents

Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors

HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription.

Approaches to optimal dosing of hexamethylene bisacetamide.

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.

Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism

P304

91-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSBMB.2017.02.008

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Nethrie D Idippily

P577

2017-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28213333

http://www.w3.org/2001/XMLSchema#string

P932

5699885

http://www.w3.org/2001/XMLSchema#string

HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.

about

P2860

P2860

HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932